Your session is about to expire
← Back to Search
Combination Therapy for Ulcerative Colitis
Study Summary
This trial is testing a new combination therapy for UC that may be more effective than existing treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 2 trial • 26 Patients • NCT03378921Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this clinical trial a pioneer endeavor in its field?
"To date, 23 clinical trials for Fecal microbiota transplantation are in progress across 312 cities and 42 countries. An inaugural experiment was initiated by Takeda back in 2015 with 260 participants to reach the final phase of drug approval; since then 40 such studies have been completed."
How many participants are the maximum that can join this trial?
"Affirmative. According to clinicaltrials.gov, the search for participants is currently ongoing and has been since May 1st 2021. The trial was recently updated on August 23rd 2022 and 10 people are sought from a single site."
Is this examination currently recruiting participants?
"Clinicaltrials.gov indicates that this trial is actively seeking subjects, with the study first announced on May 1st 2021 and revised as recenty as August 23rd 2022."
Has the FDA authorized Fecal microbiota transplantation for medical use?
"Fecal microbiota transplantation is approved for medical use and has been sufficiently studied, so it was assigned a safety rating of 3."
Share this study with friends
Copy Link
Messenger